METHYL 4-NITRO-1H-INDAZOLE-6-CARBOXYLATE, 95%, 25g

3-Methyl-2-nitrobenzoic Acid>98.0%(T)250g

tert-Butyl (2-amino-3-chlorophenyl)carbamate, 95.0%, 250mg

(2S)-2-cyclobutyl-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetic acid, 97.0%, 5g

(4-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid, 95.0%, 1g

Methyl Oleate>60.0%(GC)25mL

Récipient à échantillons Type 2116, 60 ml, 4 pièce(s)

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1H-indol-3-yl)propanoic acid, 97%, 250mg

7-Fluoro-3,4-dihydro-4-methyl-1H-1,4-benzodiazepine-2,5-dione, 95.0%, 250mg

tert-Butyl N-[1-(5-bromo-2-pyridyl)-4-piperidyl]carbamate, 98%, 5g

Sophoridine>98.0%(GC)(T)250mg

Dimethyl 2,2'-thiobisacetate, 99.0%, 10g

(R)-1-((Benzyloxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid, 98%, 100mg